Result of AGM
08 Septiembre 2008 - 4:53AM
UK Regulatory
RNS Number : 9250C
Vivomedica PLC
08 September 2008
For immediate release 8 September 2008
VivoMedica plc
("VivoMedica" or the "Company")
Annual General Meeting Result
VivoMedica plc (AIM:VVM) the pharmaware company, announces that all the resolutions were duly passed at the Company's Annual General
Meeting held today.
A summary of proxy votes for each Resolution is below.
Resolution Percentage Votes For
1. To receive and adopt the financial statements for 99.6%
the year ended 31 December 2007
2. To re-appoint KPMG Audit Plc as Auditors of the 99.9%
Company
3. To re-elect, as a Director, Peter Leyland 98.7%
4. To re-elect, as a Director, Alan Edwards 98.7%
5. To re-elect, as a Director, Susan Veness 98.6%
6. To authorise the Directors to allot relevant 97.6%
securities
7. That the Directors be generally empowered pursuant 96.5%
to Section 95 of the Act to allot equity securities
For further information, please contact:
VivoMedicaPeter Leyland, Chief Executive OfficerSusan Veness, 01795 414460
Finance Director
Brewin Dolphin Investment Banking (NOMAD)Mark Brady / Alison 0845 270 8600
Barrow
Buchanan CommunicationsTim Anderson / Catherine Breen 020 7466 5000
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGKGGGLLRGGRZG
Vivomedica (LSE:VVM)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Vivomedica (LSE:VVM)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Vivomedica (London Stock Exchange): 0 recent articles
Más de Vivomedica Plc Artículos de Noticias